NDC 86211-105-18 - Vetprofen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 86211-105
- Requested NDC
- 86211-105-18
- Package NDCs from labels
- 86211-105-18
- Manufacturer
- JVET PHARMACEUTICALS LLC | AJENAT PHARMACEUTICALS LLC
- Effective date
- 2025-12-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Vetprofen - JVET PHARMACEUTICALS LLC | AJENAT PHARMACEUTICALS LLC | JVET PHARMACEUTICALS LLC | AJENAT PHARMACEUTICALS LLC | 2025-12-22 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 86211-105-18 | Vetprofen | 180 in 1 BOTTLE, PLASTIC | TABLET | 180 | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glatiramer Acetate | GLATIRAMER ACETATE | AJENAT PHARMACEUTICALS LLC | 7a573ffb-5dd7-43b7-8633-c69f303b1bbf | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | AJENAT PHARMACEUTICALS LLC |
| Glatiramer Acetate | GLATIRAMER ACETATE | AJENAT PHARMACEUTICALS LLC | 1ec10223-880d-402f-a759-9cd179bf09de | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | AJENAT PHARMACEUTICALS LLC |
| testosterone cypionate | TESTOSTERONE CYPIONATE | Ajenat Pharmaceuticals LLC | cd57648c-ce53-459a-9f14-3984fc464428 | 2026-09-09 | Warnings, Adverse reactions | Ajenat Pharmaceuticals LLC |
| Methocarbamol | METHOCARBAMOL | JVET PHARMACEUTICALS LLC | d9e4748f-11c5-4d87-b260-1be94febe806 | 2026-05-22 | Warnings, Adverse reactions | JVET PHARMACEUTICALS LLC |
| Potassium Chloride | POTASSIUM CHLORIDE | Ajenat Pharmaceuticals LLC | ab066a84-5455-419e-a1da-354a3f15a73d | 2026-03-23 | Warnings, Adverse reactions | Ajenat Pharmaceuticals LLC |
| Ondansetron | ONDANSETRON | JVET PHARMACEUTICALS LLC | 95ca0d81-a0a8-441d-820e-cb6624018a15 | 2026-03-23 | Warnings, Adverse reactions | JVET PHARMACEUTICALS LLC |
| DOXYCYCLINE | DOXYCYCLINE | JVET PHARMACEUTICALS LLC | ed95709e-2a1a-4deb-88bd-5b99f02b7a26 | 2026-01-27 | Warnings, Adverse reactions | JVET PHARMACEUTICALS LLC |
| Tobramycin | TOBRAMYCIN | JVET PHARMACEUTICALS LLC | c6435b8f-bb6e-45e0-a52b-3087fd043b5a | 2026-01-26 | Warnings, Adverse reactions | JVET PHARMACEUTICALS LLC |
| Gabapentin | GABAPENTIN | Ajenat Pharmaceuticals LLC | 02304deb-7b4a-452f-9b1a-64ca0aedbcc2 | 2025-12-29 | Warnings, Adverse reactions | Ajenat Pharmaceuticals LLC |
| Potassium Chloride for Oral Solution | POTASSIUM CHLORIDE FOR ORAL SOLUTION | Ajenat Pharmaceuticals LLC | c62c5704-3667-4d4f-8230-3f7f5ed825b1 | 2025-12-29 | Warnings, Adverse reactions | Ajenat Pharmaceuticals LLC |
| Tacrolimus | TACROLIMUS | Ajenat Pharmaceuticals LLC | ca08d4aa-3de2-4a9d-9554-6288e5d36f29 | 2025-12-29 | Boxed warning, Warnings, Adverse reactions | Ajenat Pharmaceuticals LLC |
| Glycopyrrolate Oral Solution | GLYCOPYRROLATE | AJENAT PHARMACEUTICALS LLC | 7049feaf-004a-481f-b129-996b21c3170a | 2025-12-29 | Warnings, Adverse reactions | AJENAT PHARMACEUTICALS LLC |
| Phenobarbital Oral Solution | PHENOBARBITAL ORAL | Ajenat Pharmaceuticals LLC | adf9382d-9fa3-4574-bfcd-e92a8b3433e6 | 2025-12-29 | Warnings, Adverse reactions | Ajenat Pharmaceuticals LLC |
| Lacosamide Oral Solution | LACOSAMIDE | Ajenat Pharmaceuticals LLC | cb29da34-89aa-405a-8fbc-2308bda37187 | 2025-12-29 | Warnings, Adverse reactions | Ajenat Pharmaceuticals LLC |
| Dehydrated Alcohol | ALCOHOL | Ajenat Pharmaceuticals LLC | 636d6421-cadf-42b3-a431-ba40c06e36d2 | 2025-12-29 | Warnings, Adverse reactions | Ajenat Pharmaceuticals LLC |
| Midazolam Hydrochloride | MIDAZOLAM HYDROCHLORIDE | Jvet Pharmaceuticals LLC | a84ddd02-1f5f-4311-9dae-2a5cb4064bf3 | 2025-12-22 | Boxed warning, Warnings, Adverse reactions | Jvet Pharmaceuticals LLC |
| Glycopyrrolate | GLYCOPYRROLATE | Jvet Pharmaceuticals LLC | 4b335c67-4f8f-47e5-abfc-f8c2c15496d7 | 2025-12-19 | Warnings, Adverse reactions | Jvet Pharmaceuticals LLC |
| Gabapentin | GABAPENTIN | JVET PHARMACEUTICALS LLC | 63a5fc6d-ca57-4726-b70d-805ac023d959 | 2025-12-10 | Warnings, Adverse reactions | JVET PHARMACEUTICALS LLC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.